Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03124303 · ClinicalTrials.gov registry record
Interventions for Postoperative Delirium: Biomarker-3
A clinical trial of Delirium, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 468
- Enrollment target
- 1
- Study location
NCT03124303: Recruiting study of Delirium, sponsored by University of Wisconsin, Madison.
NCT03124303 is a study of Delirium that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 468 participants, below the 880-participant average among 62 other Delirium trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03124303, a study of Delirium, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 468 participants
- Enrollment target
- 1
- Study location
Study Summary
The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.
Primary Outcome
Change from baseline functional connectivity at immediate postoperative period and association between delirium (CAM) and functional connectivity of the cingulate cortex
Conditions Studied
Interventions
- PROCEDURE Magnetic Resonance Imaging
- PROCEDURE High Density-Electroencephalogram
- PROCEDURE Blood specimen collection
- DIAGNOSTIC_TEST Pupillometry
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 468 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2029-12 |
What NCT03124303 shows while recruiting
NCT03124303 is an observational study that tracks outcomes without assigning an intervention. The registered 468 participants enrollment target is mid-sized for trials with a published cap, below the 880-participant average among 62 other Delirium trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 4 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT03124303 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03124303 about?
NCT03124303 is a clinical study titled "Interventions for Postoperative Delirium: Biomarker-3". The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.
What is the current status of trial NCT03124303?
This trial is currently recruiting. The enrollment target is 468 participants. The study started on 2017-02-13. Estimated completion is 2029-12.
What conditions does trial NCT03124303 study?
This clinical trial studies the following conditions: Delirium.
What interventions are being tested in trial NCT03124303?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), High Density-Electroencephalogram (PROCEDURE), Blood specimen collection (PROCEDURE), Pupillometry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03124303?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03124303 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03124303's enrollment target sits among peer trials
468 17th of 62 higher than 46 of 62 other Delirium trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03901924 · 468 participants · NA
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
- NCT04482309 · 468 participants · Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
- NCT05357170 · 468 participants
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
- NCT05426057 · 468 participants · NA
Mental Health in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI